| Title: | Model-based assessment of replicability for genome-wide association meta-analysis |
| Journal: | Nature Communications |
| Published: | 30 Mar 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33785739/ |
| DOI: | https://doi.org/10.1038/s41467-021-21226-z |
| URL: | https://www.nature.com/articles/s41467-021-21226-z.pdf |
Publication 9620
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Genome-wide association meta-analysis (GWAMA) is an effective approach to enlarge sample sizes and empower the discovery of novel associations between genotype and phenotype. Independent replication has been used as a gold-standard for validating genetic associations. However, as current GWAMA often seeks to aggregate all available datasets, it becomes impossible to find a large enough independent dataset to replicate new discoveries. Here we introduce a method, MAMBA (Meta-Analysis Model-based Assessment of replicability), for assessing the "posterior-probability-of-replicability" for identified associations by leveraging the strength and consistency of association signals between contributing studies. We demonstrate using simulations that MAMBA is more powerful and robust than existing methods, and produces more accurate genetic effects estimates. We apply MAMBA to a large-scale meta-analysis of addiction phenotypes with 1.2 million individuals. In addition to accurately identifying replicable common variant associations, MAMBA also pinpoints novel replicable rare variant associations from imputation-based GWAMA and hence greatly expands the set of analyzable variants.</p>
12 Authors
- Daniel McGuire
- Yu Jiang
- Mengzhen Liu
- J. Dylan Weissenkampen
- Scott Eckert
- Lina Yang
- Fang Chen
- Arthur Berg
- Scott Vrieze
- Bibo Jiang
- Qunhua Li
- Dajiang J. Liu
Enabling scientific discoveries that improve human health